SCYXSCYNEXIS, Inc.

5.100USD-0.97%Mkt Cap: 50.74M $P/E:

SCYNEXIS, Inc., a biotechnology company, engages in drug development for the treatment and prevention of difficult-to-treat and drug-resistant fungal infections in the United States. The company offers BREXAFEMME for the…